Tealwood Asset Management Inc. Sells 315 Shares of Hologic, Inc. (NASDAQ:HOLX)
Tealwood Asset Management Inc. Sells 315 Shares of Hologic, Inc. (NASDAQ:HOLX)
Tealwood Asset Management Inc. lessened its stake in shares of Hologic, Inc. (NASDAQ:HOLX – Get Rating) by 1.9% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 16,310 shares of the medical equipment provider's stock after selling 315 shares during the period. Tealwood Asset Management Inc.'s holdings in Hologic were worth $1,130,000 at the end of the most recent quarter.
根據蒂爾伍德資產管理公司(Tealwood Asset Management Inc.)向美國證券交易委員會披露的最新信息，該公司在第二季度減持了霍洛奇公司(Sequoia Capital，Inc.)的股份，減持幅度為1.9%。在此期間出售了315股後，該機構投資者持有這家醫療設備提供商的股票16,310股。截至最近一個季度末，蒂爾伍德資產管理公司(Tealwood Asset Management Inc.)持有的霍洛奇股份價值1,130,000美元。
Several other institutional investors and hedge funds have also recently modified their holdings of HOLX. Rockefeller Capital Management L.P. raised its stake in shares of Hologic by 5.2% during the fourth quarter. Rockefeller Capital Management L.P. now owns 9,956 shares of the medical equipment provider's stock valued at $761,000 after acquiring an additional 494 shares in the last quarter. LPL Financial LLC raised its stake in Hologic by 14.0% in the fourth quarter. LPL Financial LLC now owns 194,232 shares of the medical equipment provider's stock worth $14,870,000 after buying an additional 23,884 shares in the last quarter. Alliancebernstein L.P. raised its stake in Hologic by 18.3% in the fourth quarter. Alliancebernstein L.P. now owns 443,062 shares of the medical equipment provider's stock worth $33,921,000 after buying an additional 68,664 shares in the last quarter. Impax Asset Management Group plc raised its stake in Hologic by 2.2% in the fourth quarter. Impax Asset Management Group plc now owns 12,267 shares of the medical equipment provider's stock worth $939,000 after buying an additional 264 shares in the last quarter. Finally, Guggenheim Capital LLC raised its stake in Hologic by 12.9% in the fourth quarter. Guggenheim Capital LLC now owns 78,904 shares of the medical equipment provider's stock worth $6,041,000 after buying an additional 9,031 shares in the last quarter. Institutional investors own 85.70% of the company's stock.
其他幾家機構投資者和對衝基金最近也調整了對HOLX的持股。洛克菲勒資本管理公司(Rockefeller Capital Management L.P.)在第四季度將其在霍洛奇公司的股份增加了5.2%。洛克菲勒資本管理公司(Rockefeller Capital Management L.P.)在上個季度增持了494股股票後，現在擁有這家醫療設備提供商9956股股票，價值76.1萬美元。LPL Financial LLC在第四季度將其在霍洛奇的持股比例提高了14.0%。LPL Financial LLC現在擁有這家醫療設備提供商194,232股股票，價值14，87萬美元，上個季度又購買了23,884股。聯合伯恩斯坦公司在第四季度將其在霍洛奇公司的持股比例提高了18.3%。聯合伯恩斯坦公司現在持有這家醫療設備提供商443,062股股票，價值33,921,000美元，上個季度又購買了68,664股。Impax Asset Management Group plc在第四季度將其在霍洛奇的持股增加了2.2%。Impax Asset Management Group plc現在持有這家醫療設備提供商12,267股股票，價值93.9萬美元，上個季度又購買了264股。最後，古根海姆資本有限責任公司在第四季度將其在霍洛奇公司的持股比例提高了12.9%。Guggenheim Capital LLC現在持有這家醫療設備提供商78,904股股票，價值6,041,000美元，上個季度又購買了9,031股。機構投資者持有該公司85.70%的股票。
Wall Street Analysts Forecast Growth
華爾街分析師預測經濟增長
HOLX has been the subject of a number of recent research reports. Morgan Stanley reduced their price objective on shares of Hologic from $72.00 to $70.00 and set an "equal weight" rating for the company in a research note on Thursday, July 28th. Bank of America downgraded shares of Hologic from a "buy" rating to a "neutral" rating and reduced their price objective for the stock from $81.00 to $75.00 in a research note on Wednesday, July 20th. BTIG Research lowered shares of Hologic from a "buy" rating to a "neutral" rating in a report on Monday, July 18th. Finally, UBS Group began coverage on shares of Hologic in a report on Wednesday, July 20th. They issued a "neutral" rating and a $73.00 price target on the stock. Seven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $76.71.
HOLX是最近一些研究報告的主題。7月28日，週四，摩根士丹利在一份研究報告中將霍洛奇股票的目標價從72.00美元下調至70.00美元，併為該公司設定了“同等權重”的評級。在7月20日星期三的一份研究報告中，美國銀行將霍洛奇的股票評級從買入下調至中性，並將該股的目標價從81.00美元下調至75.00美元。在7月18日星期一的一份報告中，BTIG Research將霍洛奇的股票評級從“買入”下調至“中性”。最後，瑞銀集團在7月20日星期三的一份報告中開始報道霍洛奇的股票。他們對該股給予了“中性”評級和73.00美元的目標價。7名股票研究分析師對該股的評級為持有，4名分析師對該公司的評級為買入。根據MarketBeat.com的數據，該公司的共識評級為持有，共識目標價為76.71美元。
Hologic Stock Performance
霍洛奇股票表現
Hologic (NASDAQ:HOLX – Get Rating) last announced its quarterly earnings data on Wednesday, July 27th. The medical equipment provider reported $0.95 earnings per share for the quarter, beating analysts' consensus estimates of $0.69 by $0.26. The firm had revenue of $1 billion for the quarter, compared to analyst estimates of $896.71 million. Hologic had a net margin of 28.93% and a return on equity of 37.48%. The business's quarterly revenue was down 14.2% compared to the same quarter last year. During the same period in the previous year, the company earned $1.33 earnings per share. Equities analysts anticipate that Hologic, Inc. will post 5.82 EPS for the current fiscal year.
納斯達克(HOLX：HOLX-GET Rating)上一次公佈季度收益數據是在7月27日星期三。這家醫療設備供應商公佈本季度每股收益為0.95美元，比分析師普遍預期的0.69美元高出0.26美元。該公司本季度營收為10億美元，而分析師預期為8.9671億美元。霍洛奇的淨利潤率為28.93%，股本回報率為37.48%。與去年同期相比，該業務的季度收入下降了14.2%。去年同期，該公司每股收益為1.33美元。股票分析師預計，霍洛奇公司本財年每股收益將達到5.82美元。
About Hologic
關於霍洛奇
(Get Rating)
(獲取評級)
Hologic, Inc develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health.
霍洛奇公司在美國、歐洲、亞太地區和國際上開發、製造和供應診斷產品、醫學成像系統和外科產品，通過早期發現和治療來保護婦女的健康。它通過四個部分運作：診斷、乳房健康、婦科外科和骨骼健康。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on Hologic (HOLX)
- 2 Casino Stocks Worth Taking a Look At
- This Small-Cap Healthcare Name Is Outperforming Its Index
- What Cintas Can Teach Investors About This Bear Market?
- Blackberry Stock Declines As Results Come In Lukewarm Once Again
- A Trio of Q3 Winners With Room to Run
- 免費獲取StockNews.com關於霍洛奇的研究報告(HOLX)
- 值得一看的2只賭場股票
- 這家小盤股醫療保健公司的表現好於其指數
- 關於這個熊市，Cintas能教給投資者什麼？
- 黑莓股價下跌，業績再次不温不火
- 第三季度贏家三人組還有運行的空間
Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.
接受《荷蘭語日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對霍洛奇及相關公司的最新新聞和分析師評級的每日簡要摘要。